Report Detail
Global Inavolisib Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4706223 |
- 09 June, 2026 |
- Global |
- 77 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Inavolisib Tablets market size was valued at US$ 171 million in 2025 and is forecast to a readjusted size of US$ 940 million by 2032 with a CAGR of 22.5% during review period.
Inavolisib is an orally administered small-molecule selective inhibitor of PI3Kα (phosphatidylinositol 3-kinase alpha isoform). It is primarily used for the treatment of patients with PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced or metastatic breast cancer. The drug exerts its anti-tumor effects by selectively inhibiting the PI3K/AKT/mTOR signaling pathway, thereby blocking tumor cell proliferation and survival signals.
Inavolisib is typically used in combination with endocrine therapy and CDK4/6 inhibitors. It has significant clinical value in delaying disease progression and improving patient outcomes, and represents a new generation of advances in PI3K-targeted therapy.In 2025, global Inavolisib production reached approximately 30,000 bottles.
Inavolisib, as a new-generation PI3Kα-selective inhibitor, holds significant development potential in the treatment market for hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced or metastatic breast cancer with PIK3CA mutations. With the continuous rise in global breast cancer incidence and the increasing penetration of precision molecular diagnostics—particularly PIK3CA testing—the PI3K pathway-targeted therapy market is gradually expanding.
Compared with first-generation PI3K inhibitors, Inavolisib demonstrates improved selectivity, safety, and potential in combination therapy with CDK4/6 inhibitors, which may enhance its clinical utilization. From a competitive landscape perspective, the field already includes established products such as alpelisib. However, Inavolisib is expected to achieve differentiated competition in the future due to its superior clinical data and combination treatment strategies.
Looking ahead, with ongoing global regulatory approvals, standardization of combination therapy regimens, and expansion of reimbursement coverage, its market size is expected to grow rapidly, securing an important position in the HR+/HER2− breast cancer precision therapy landscape.
This report is a detailed and comprehensive analysis for global Inavolisib Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Inavolisib Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Inavolisib Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Inavolisib Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Inavolisib Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Inavolisib Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Inavolisib Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Genentech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Inavolisib Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
5 mg
10 mg
Market segment by Sales Channel
Hospital
Retail
Online
Market segment by Route of Administration
Oral Administration
Intravenous Administration, IV
Market segment by Dosage Forms
Tablet
Capsule
Market segment by Application
HR+/HER2- Advanced or Metastatic Breast Cancer
PIK3CA-Mutated Tumor Targeted Therapy
Combination Therapy Applications
Others
Major players covered
Roche
Genentech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inavolisib Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Inavolisib Tablets, with price, sales quantity, revenue, and global market share of Inavolisib Tablets from 2021 to 2026.
Chapter 3, the Inavolisib Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inavolisib Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Inavolisib Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Inavolisib Tablets.
Chapter 14 and 15, to describe Inavolisib Tablets sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Inavolisib Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 5 mg
- 1.3.3 10 mg
- 1.4 Market Analysis by Sales Channel
- 1.4.1 Overview: Global Inavolisib Tablets Consumption Value by Sales Channel: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Retail
- 1.4.4 Online
- 1.5 Market Analysis by Route of Administration
- 1.5.1 Overview: Global Inavolisib Tablets Consumption Value by Route of Administration: 2021 Versus 2025 Versus 2032
- 1.5.2 Oral Administration
- 1.5.3 Intravenous Administration, IV
- 1.6 Market Analysis by Dosage Forms
- 1.6.1 Overview: Global Inavolisib Tablets Consumption Value by Dosage Forms: 2021 Versus 2025 Versus 2032
- 1.6.2 Tablet
- 1.6.3 Capsule
- 1.7 Market Analysis by Application
- 1.7.1 Overview: Global Inavolisib Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 HR+/HER2- Advanced or Metastatic Breast Cancer
- 1.7.3 PIK3CA-Mutated Tumor Targeted Therapy
- 1.7.4 Combination Therapy Applications
- 1.7.5 Others
- 1.8 Global Inavolisib Tablets Market Size & Forecast
- 1.8.1 Global Inavolisib Tablets Consumption Value (2021 & 2025 & 2032)
- 1.8.2 Global Inavolisib Tablets Sales Quantity (2021-2032)
- 1.8.3 Global Inavolisib Tablets Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche Inavolisib Tablets Product and Services
- 2.1.4 Roche Inavolisib Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Roche Recent Developments/Updates
- 2.2 Genentech
- 2.2.1 Genentech Details
- 2.2.2 Genentech Major Business
- 2.2.3 Genentech Inavolisib Tablets Product and Services
- 2.2.4 Genentech Inavolisib Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Genentech Recent Developments/Updates
3 Competitive Environment: Inavolisib Tablets by Manufacturer
- 3.1 Global Inavolisib Tablets Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Inavolisib Tablets Revenue by Manufacturer (2021-2026)
- 3.3 Global Inavolisib Tablets Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Inavolisib Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Inavolisib Tablets Manufacturer Market Share in 2025
- 3.4.3 Top 6 Inavolisib Tablets Manufacturer Market Share in 2025
- 3.5 Inavolisib Tablets Market: Overall Company Footprint Analysis
- 3.5.1 Inavolisib Tablets Market: Region Footprint
- 3.5.2 Inavolisib Tablets Market: Company Product Type Footprint
- 3.5.3 Inavolisib Tablets Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Inavolisib Tablets Market Size by Region
- 4.1.1 Global Inavolisib Tablets Sales Quantity by Region (2021-2032)
- 4.1.2 Global Inavolisib Tablets Consumption Value by Region (2021-2032)
- 4.1.3 Global Inavolisib Tablets Average Price by Region (2021-2032)
- 4.2 North America Inavolisib Tablets Consumption Value (2021-2032)
- 4.3 Europe Inavolisib Tablets Consumption Value (2021-2032)
- 4.4 Asia-Pacific Inavolisib Tablets Consumption Value (2021-2032)
- 4.5 South America Inavolisib Tablets Consumption Value (2021-2032)
- 4.6 Middle East & Africa Inavolisib Tablets Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Inavolisib Tablets Sales Quantity by Type (2021-2032)
- 5.2 Global Inavolisib Tablets Consumption Value by Type (2021-2032)
- 5.3 Global Inavolisib Tablets Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Inavolisib Tablets Sales Quantity by Application (2021-2032)
- 6.2 Global Inavolisib Tablets Consumption Value by Application (2021-2032)
- 6.3 Global Inavolisib Tablets Average Price by Application (2021-2032)
7 North America
- 7.1 North America Inavolisib Tablets Sales Quantity by Type (2021-2032)
- 7.2 North America Inavolisib Tablets Sales Quantity by Application (2021-2032)
- 7.3 North America Inavolisib Tablets Market Size by Country
- 7.3.1 North America Inavolisib Tablets Sales Quantity by Country (2021-2032)
- 7.3.2 North America Inavolisib Tablets Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Inavolisib Tablets Sales Quantity by Type (2021-2032)
- 8.2 Europe Inavolisib Tablets Sales Quantity by Application (2021-2032)
- 8.3 Europe Inavolisib Tablets Market Size by Country
- 8.3.1 Europe Inavolisib Tablets Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Inavolisib Tablets Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Inavolisib Tablets Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Inavolisib Tablets Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Inavolisib Tablets Market Size by Region
- 9.3.1 Asia-Pacific Inavolisib Tablets Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Inavolisib Tablets Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Inavolisib Tablets Sales Quantity by Type (2021-2032)
- 10.2 South America Inavolisib Tablets Sales Quantity by Application (2021-2032)
- 10.3 South America Inavolisib Tablets Market Size by Country
- 10.3.1 South America Inavolisib Tablets Sales Quantity by Country (2021-2032)
- 10.3.2 South America Inavolisib Tablets Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Inavolisib Tablets Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Inavolisib Tablets Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Inavolisib Tablets Market Size by Country
- 11.3.1 Middle East & Africa Inavolisib Tablets Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Inavolisib Tablets Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Inavolisib Tablets Market Drivers
- 12.2 Inavolisib Tablets Market Restraints
- 12.3 Inavolisib Tablets Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Inavolisib Tablets and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Inavolisib Tablets
- 13.3 Inavolisib Tablets Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Inavolisib Tablets Typical Distributors
- 14.3 Inavolisib Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Inavolisib Tablets. Industry analysis & Market Report on Inavolisib Tablets is a syndicated market report, published as Global Inavolisib Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Inavolisib Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
